Table 3.

Data of electroencephalography, neuroimaging, treatment and outcome of afebrile and febrile groups.

	Group		P-value
	Afebrile (n = 41)	Febrile (n = 30)
Interictal EEG examination	27 (65.9%)	19 (63.3%)	0.97
Normal	16 (59.3%)	17 (89.5%)
Abnormal	11 (40.7%)	2 (10.5%)	0.04
Neuroimaging studies	12 (29.3%)	4 (13.3%)	0.19
Brain CT	10 (24.4%)	3 (10%)
Brain MRI	4 (9.8%)*	1 (3.3%)
Antiepileptic drugs use	15 (36.59%)	8 (26.67%)	0.38
Hospitalization and PICU admission
Overall admission rate	29 (70.7%)	25 (83.3%)	0.34
Length of hospitalization, d, mean ± SD	4.59 ± 1.57	5.96 ± 2.81	0.04
PICU admission	5 (12.2%)	1 (3.3%)	0.37
PICU stay, d, mean ± SD	4.2 ± 1.92	3
Prognosis and outcomes
Recurrence AGE-associated seizures	5 (12.2%)	6 (20%)	0.57
Development of epilepsy	6 (37, 16.22%)	3 (30, 10%)	0.69

Values are expressed in number of patients (%) otherwise noted.

^*Including two patients also received brain CT examinations.

SD, standard deviation; EEG, electroencephalography; CT, computed tomography; MRI, magnetic resonance imaging; PICU, pediatric intensive care unit.